• AGC completes acquisition of Malgrat Pharma Chemicals biospectrumasia
    March 04, 2019
    The acquisition of MPC has allowed the AGC Group to obtain another manufacturing and sales base outside of Japan, following the acquisitions of two biopharmaceutical CDMO companies, Biomeva (2016) and CMC Biologics (2017)
PharmaSources Customer Service